RECOMBINANT VACCINE MARKET ANALYSIS

Recombinant Vaccine Market, By Type (Attenuated Recombinant Vaccines, Vector Recombinant Vaccines, and Subunit Recombinant Vaccines), By Indication (Human Papillomavirus (HPV), Meningococcal, Hepatitis B, Influenza, Rotavirus, Herpes Zoster, and Others), By End User (Pediatric, Adult, and Geriatric), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Vaccination Centers), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI455
Pages :156
Formats :
Excel and PDF
Industry : Biotechnology

Recombinant Vaccine Market Size and Trends

The Global Recombinant Vaccine Market is estimated to be valued at USD 12.52 Bn in 2025 and is expected to reach USD 27.17 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2025 to 2032.

Key Takeaways of the Recombinant Vaccine Market:

The attenuated recombinant vaccines segment is expected to contribute the highest share of the market with 43.6% in 2025.
The Human Papillomavirus (HPV) segment is expected to contribute the highest share with 23.6% in 2025 under the indication segment.
The pediatric segment is expected to contribute the highest share under the end user segment with a share of 35.7% in 2025.
North America is expected to top the global market with 35.8% share, followed by Asia Pacific with 28.2% share in 2025.

Market Overview:

Factors such as rising prevalence of infectious diseases and increasing R&D investments are driving the demand for recombinant vaccines. Recombinant vaccine technology allows high yield and mass production of vaccines at low cost. This has led to significant growth in sales of recombinant vaccines for diseases such as influenza, hepatitis B, and HPV. Moreover, ongoing research for the development of recombinant vaccines for emerging and re-emerging diseases will provide new opportunities for market players. Continued government support for immunization programs is further expected to aid market expansion during the forecast period.